Tim Cernohous of Cencora explains why patient trust no longer guarantees satisfaction—and how automation and better communication can close the gap with mail order.
|Articles|April 27, 2022
- April 2022
- Volume 88
- Issue 4
Pet Peeves: April 2022
Brought to you by The Sassy Pharmacist
Advertisement
Spelling Bee Champion
When people spell their name instead of saying John Smith.
Coupon Clippers
When people give you manufacturer coupons at pick up.
Time Crunch
When people ask if we can get the medication ready and they’ll bring the prescription when they come to pick up, “to save time.”
What’s Bothering You?
Bossy patients, abandoned prescriptions, drive-through demands? We want to know! Send your pet peeves to [email protected]. We’ll share them here and online.
Articles in this issue
over 4 years ago
Case Studies: April 2022over 4 years ago
Generic Product News: April 2022over 4 years ago
OTC Cases: April 2022over 4 years ago
RX Product News: April 2022over 4 years ago
Bijuva From TherapeuticsMDover 4 years ago
Support Individuals Who Abuse Alcoholover 4 years ago
OTC Product News: April 2022over 4 years ago
Services to Improve Therapeutic Outcomes Improve Star Ratingsover 4 years ago
Worldwide Generics Market Will Exceed $507 Billion in 4 YearsAdvertisement
Related to this article
Eight Humira biosimilars have been launched, but payer formularies and interchangeability rules decide what dispenses.
At NEIAP 2026, Kelsey Norman, PharmD, walked through how VESALIUS-CV, Lp(a)HORIZON, and CKM guidelines change pharmacist-led lipid care.
Pharmacists can educate patients about staying up to date on immunizations and discuss fall prevention strategies.
Findings presented at the European Respiratory Society Congress 2026 suggest semaglutide may offer respiratory benefits beyond its approved diabetes and obesity indications.
Study investigator David Berg explains why volume overload shouldn't decide which hospitalized patients get an SGLT2 inhibitor.
The data helps pharmaicts predict who will react strongly to mRNA vaccines—giving them a science-backed talking point during respiratory season.
CDC-recommended adult vaccination programs for pneumococcal disease, RSV, influenza, and COVID-19 prevent over 182,000 deaths and generate up to $12 in societal value for every $1 spent.
Advertisement
Advertisement
Trending on Pharmacy Times
1
New Data Reshapes Nonstatin Lipid Therapy Choices
2
Eight Names, One Drug: Why Adalimumab Biosimilars Are Creating Real Confusion at the Counter
3
Etentamig Reduces Risk of Progression or Death by 60% in Relapsed/Refractory Multiple Myeloma
4
Comparison of Weight-Based vs Non–Weight-Based Norepinephrine Dosing in Patients With Septic Shock
5